Pazopanib (P) and cisplatin (CDDP) in patients with advanced solid tumors: A UNICANCER phase I study.

被引：2
|
作者：
Dieras, Veronique
Bachelot, Thomas
Campone, Mario
Isambert, Nicolas
Joly, Florence
Le Toumeau, Chrlstophe
Cassler, Philippe Alexandre
Bompas, Emmanuelle
Fumoloau, Pierre
Noal, Sabine
Orsini, Christina
Jimenez, Marta
Imbs, Diane Charlotte
Chatelut, Etienne
机构：
[1] Inst Curie, Paris, France
[2] Ctr Leon Berard, F-69373 Lyon, France
[3] Inst Cancerol Ouest, Nantes, France
[4] Ctr Georges Francois Leclerc, Dijon, France
[5] Ctr Francois Baclesse, Dept Med Oncol, F-14021 Caen, France
[6] Inst Curie, Dept Med Oncol, Paris, France
[7] Inst Cancerol Ouest, Dept Med Oncol, Nantes, France
[8] Ctr Francois Baclesse, F-14021 Caen, France
[9] UNICANCER, Paris, France
[10] Inst Claudius Regaud, Toulouse, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.2583
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2583
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
    Dieras, Veronique
    Bachelot, Thomas
    Campone, Mario
    Isambert, Nicolas
    Joly, Florence
    Le Tourneau, Christophe
    Cassier, Philippe
    Bompas, Emmanuelle
    Fumoleau, Pierre
    Noal, Sabine
    Orsini, Christine
    Jimenez, Marta
    Imbs, Diane Charlotte
    Chatelut, Etienne
    ONCOLOGY AND THERAPY, 2016, 4 (02) : 211 - 223
  • [2] A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
    Véronique Diéras
    Thomas Bachelot
    Mario Campone
    Nicolas Isambert
    Florence Joly
    Christophe Le Tourneau
    Philippe Cassier
    Emmanuelle Bompas
    Pierre Fumoleau
    Sabine Noal
    Christine Orsini
    Marta Jimenez
    Diane Charlotte Imbs
    Etienne Chatelut
    Oncology and Therapy, 2016, 4 (2) : 211 - 223
  • [3] Phase I dose-escalation study of brostallicin in combination with cisplatin (cDDP) in patients with advanced solid tumors
    Lorusso, D.
    Fornari, G.
    Caponigro, F.
    Quirino, M.
    Merlano, M.
    Airoldi, M.
    Schena, M.
    Jannuzzo, M. G.
    Crippa, S.
    Scambia, G.
    EJC SUPPLEMENTS, 2007, 5 (04): : 111 - 112
  • [4] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Ruth Plummer
    Ayman Madi
    Melinda Jeffels
    Heike Richly
    Bahar Nokay
    Stephen Rubin
    Howard A. Ball
    Steve Weller
    Jeffrey Botbyl
    Diana M. Gibson
    Max E. Scheulen
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 93 - 101
  • [5] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Plummer, Ruth
    Madi, Ayman
    Jeffels, Melinda
    Richly, Heike
    Nokay, Bahar
    Rubin, Stephen
    Ball, Howard A.
    Weller, Steve
    Botbyl, Jeffrey
    Gibson, Diana M.
    Scheulen, Max E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 93 - 101
  • [6] Phase 1 study of ombrabulin in combination with cisplatin (CDDP) in Japanese patients with advanced solid tumors
    Takahashi, Shunji
    Nakano, Kenji
    Yokota, Tomoya
    Shitara, Kohei
    Muro, Kei
    Sunaga, Yoshinori
    Ecstein-Fraisse, Evelyne
    Ura, Takashi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (11) : 1000 - 1007
  • [7] Phase I Study of Pazopanib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumors
    Tan, Antoinette R.
    Dowlati, Afshin
    Jones, Suzanne F.
    Infante, Jeffrey R.
    Nishioka, Jennifer
    Fang, Lei
    Hodge, Jeffrey P.
    Gainer, Shelby D.
    Arumugham, Thangam
    Suttle, A. Benjamin
    Dar, Mohammed M.
    Lager, Joanne J.
    Burris, Howard A., III
    ONCOLOGIST, 2010, 15 (12): : 1253 - 1261
  • [8] PHASE I STUDY OF OMBRABULIN IN COMBINATION WITH CISPLATIN (CDDP) ADMINISTERED EVERY 3 WEEKS TO JAPANESE PATIENTS WITH ADVANCED SOLID TUMORS
    Takahashi, S.
    Ura, T.
    Nakano, K.
    Chin, K.
    Yokoyama, M.
    Hatake, K.
    Yokota, T.
    Shitara, K.
    Muro, K.
    Aoyama, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 110 - 110
  • [9] Phase I study of the combination of temsirolimus and pazopanib in advanced solid tumors
    Semrad, Thomas J.
    Eddings, Courtney
    Dutia, Mrinal P.
    Christensen, Scott
    Lara, Primo N.
    ANTI-CANCER DRUGS, 2013, 24 (06) : 636 - 640
  • [10] Phase I study of pazopanib and ixabepilone in patients with solid tumors
    Ganesan, Chitra
    Jha, Gautam
    Bliss, Robin
    Dudek, Arkadiusz Z.
    CANCER RESEARCH, 2012, 72
12345